Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 19, 2022Journal of Hematology & OncologyOpen Access

Worked to the bone: antibody-based conditioning as the future of transplant biology

View Full Paper
Ask AI
Bookmark
Share

Authors

JGJames M. GriffinUniversity Hospitals Coventry and Warwickshire NHS TrustFHFiona HealyTemple Street Children's University HospitalLDLekh N. DahalUniversity of Liverpool

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Griffin et al. (2022) studied this question.

synapsesocial.com/papers/6a120fd48edbaba0bf6696aahttps://doi.org/10.1186/s13045-022-01284-6
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia2018 · 270 citations
  2. 2Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant2016 · 3 citations
  3. 3Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma2013 · 123 citations
  4. 4The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules2021 · 122 citations
  5. 590Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma2011 · 67 citations